Chronic myeloid leukemia as a secondary malignancy after diffuse large B-cell lymphoma
Ha-young Lee, Kyung Hee Lee, Myung Soo Hyun, Min Kyoung Kim, Sung Ae Koh, Hee Soon Cho
Korean J Intern Med. 2014;29(2):250-252. Published online 2014 Feb 27 DOI: https://doi.org/10.3904/kjim.2014.29.2.250
Citations to this article as recorded by 
Chronic Myeloid Leukemia Following Treatment for Primary Neoplasms or Other Medical Conditions
Lian-He Yang, Pu Su, Catherine Luedke, Chuanyi Mark Lu, Abner Louissaint, Chad M McCall, Sarah Rapisardo, Bethany Vallangeon, Endi Wang
American Journal of Clinical Pathology.2018; 150(3): 246. CrossRef
Incidences and outcomes of therapy-related chronic myeloid leukemia in the era of tyrosine kinase inhibitors: Surveillance of the CML Cooperative Study Group
Noriyoshi Iriyama, Michihide Tokuhira, Tomoiku Takaku, Eriko Sato, Maho Ishikawa, Tomonori Nakazato, Kei-Ji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Yoshihiro Hatta, Masahiro Kizaki, Norio Komatsu, Norio Asou, Tatsuya Kawaguchi
Leukemia Research.2017; 54: 55. CrossRef
Sequential development of chronic myelogenous leukemia and primary myelofibrosis in a patient with history of large B-cell lymphoma treated with radiotherapy and chemotherapy: two myeloid neoplasms with distinct genotypic profiles suggestive of biclonalit
Bin Wu, Kimberly Ingersoll, Catherine Rehder, Siby Sebastian, Endi Wang
Annals of Hematology.2016; 95(8): 1383. CrossRef